XDH and hyperuricemia: S. vaninii polysaccharides can reverse elevated serum uric acid levels, and reduce serum and hepatic xanthine oxidase (XO) activity in hyperuricemic mice [17], positioning them as potential candidates for gout adjunctive therapies and hyperuricemia.